Stress & Contrast

Stress Echocardiography and Non-Echocardiographic Stress Testing

Overview of Stress Echocardiography

  • Primary indication: Evaluation and assessment of Coronary Artery Disease (CAD).

  • Additional clinical indications:

    • Assessment of aortic stenosis, specifically low-gradient aortic stenosis where the aortic valve area (AVA) is small, but peak velocity and mean pressure gradients are not markedly elevated.

    • Assessment of mitral regurgitation or mitral stenosis classified as moderate or greater severity in patients who remain asymptomatic.

  • Anatomy limitations: Transthoracic echocardiography cannot directly visualize the coronary arteries beyond their ostial origins.

  • Core mechanism: Introducing stress (exercise or pharmacological) increases myocardial workload and oxygen demand, unmasking or exacerbating underlying valvular dysfunction and regional wall motion abnormalities.

Non-Echocardiographic Stress Tests

  • Exercise Tolerance Test (ETT / ECG Stress Test):

    • Most common initial non-invasive stress testing modality.

    • Uses a continuous electrocardiogram (ECG) to monitor cardiac electrical activity while the patient exercises on a treadmill until reaching target heart rate.

    • Heart Rate Formulas:

      • Maximum Heart Rate (Max HR)=220−age\text{Maximum Heart Rate (Max HR)} = 220 - \text{age}

      • Target Heart Rate=(220−age)×85%\text{Target Heart Rate} = (220 - \text{age}) \times 85\%

      • Target Heart Rate Range=85% to 90% of Max HR\text{Target Heart Rate Range} = 85\% \text{ to } 90\% \text{ of Max HR}

    • Diagnostic Threshold for Ischemia: ST-segment depression >1 mm> 1\,m\text{m} on ECG.

    • Diagnostic Limitation: ST-segment depression >1 mm> 1\,m\text{m} occurs in 20%20\% of normal, non-ischemic patients; therefore, it is non-definitive and cannot serve as the sole indicator for myocardial ischemia.

  • MIBI (Nuclear Medicine Stress Test):

    • Detects exercise-induced myocardial perfusion abnormalities using a radiopharmaceutical agent.

    • Radiotracer: Methoxy IsoButyl Isonitrile (MIBI), which accumulates within viable cardiac tissue.

    • Protocol: Injected at peak stress (exercise) and at rest on separate days or times, followed by image comparison via nuclear medicine detectors.

    • Diagnostic Sensitivity: Stress echocardiography detects CAD earlier in the ischemic cascade than standard ECG stress testing and prior to the onset of clinical angina.

Stress Echocardiography Modalities and Protocols

Exercise Stress Modalities

  • Treadmill Stress Testing:

    • Protocols: Bruce Protocol, Modified Bruce Protocol, and Naughton Protocol.

    • Workflow: Patient exercises to target heart rate, then immediately transitions to an examination bed for imaging.

    • Imaging limitation: Peak exercise images cannot be acquired during active treadmill walking/running.

    • Bruce Protocol Specifics:

      • Incline and treadmill speed increase systematically every 3 minutes3\,\text{minutes}.

      • Increases the Metabolic Equivalent of Task (MET) with each stage.

      • MET Definition: Quantitative measurement of cardiac workload and systemic oxygen consumption.

      • 1 MET=3.5 mL oxygen/kg/minute\text{1 MET} = 3.5\,\text{mL oxygen/kg/minute}

      • Activities of daily living require a minimum workload of 5 METs5\,\text{METs}.

  • Bicycle Stress Testing:

    • Equipment: Standard upright exercise bicycle or specialized recumbent bicycle.

    • Recumbent Bicycle Advantage: Allows continuous echocardiographic imaging during peak cycling, enabling direct acquisition of peak stress images.

    • Workload increments occur at regular protocol intervals.

    • Hemodynamic Effect: Recumbent positioning increases venous return, which may cause transient left ventricular (LV) dilatation in normal individuals.

Pharmacological Stress Testing

  • Dobutamine (DOB) Stress Echocardiography:

    • Indicated for patients unable to perform physical exercise.

    • Pharmacological Agents:

      • Dobutamine (primary synthetic catecholamine and direct inotrope/chronotrope).

      • Persantine (Dipyridamole).

      • Atropine (used as an adjunctive agent to increase heart rate or counteract peripheral reflex responses).

    • Advantage: Allows continuous echocardiographic visualization as drug concentration increases.

    • Imaging Stages: Images captured at Rest, Low Dose, High Dose, and Post-Stress.

    • Hemodynamic Complications: Dobutamine may induce peripheral reflex responses leading to transient severe hypotension or hypertension; Atropine is administered to counteract reflex effects or assist in reaching target heart rate.

    • Safety Requirements: Intravenous (IV) access established by a nurse or certified sonographer, presence of a cardiologist, and an available crash cart for immediate resuscitation if necessary.

    • Dobutamine Endpoints (Criteria to Stop Administration):

      1. Achievement of maximum target dose/heart rate protocol.

      2. Detection of a definite new or worsening regional wall motion abnormality involving ≥2\ge 2 adjacent myocardial segments.

      3. Appearance of ST-segment elevation on the continuous ECG.

Ischemic Response and Interpretation Criteria

Normal vs. Ischemic Left Ventricular Response

  • Normal Left Ventricle Response:

    • Myocardium becomes hyperdynamic during stress.

    • Demonstrates increased systolic wall thickening and hypercontractility to meet heightened oxygen demand.

  • Ischemic Left Ventricle Response (CAD):

    • Exhibits localized kinetic impairment (hypokinesis, akinesis, or dyskinesis) in myocardial segments supplied by stenotic coronary arteries.

ECG Criteria for High Probability of CAD

  • ST-Segment Changes:

    • ST-segment depression >1–2 mm> 1\text{--}2\,\text{mm}.

    • Downsloping ST-segment morphology.

    • ST-segment depression persisting >6 minutes> 6\,\text{minutes} into the recovery phase.

    • ST-segment changes present across ≥5\ge 5 ECG leads.

    • Early-onset ST changes (manifesting within 6 minutes6\,\text{minutes} of stress initiation).

  • Hemodynamic Response:

    • Exertional hypotension (drop in systolic blood pressure during stress).

Myocardial Viability Assessment

  • Infarcted (Non-Viable) Myocardium:

    • Shows persistent absence of contraction/thickening with no change throughout all stress stages (rest, low-dose, and high-dose dobutamine).

  • Hibernating Myocardium (Biphasic Response):

    • Exhibits improved contractile function during low-dose dobutamine stimulation (recruitment of contractile reserve).

    • Deteriorates in contractile function (worsened hypokinesis or akinesis) during high-dose dobutamine stimulation as ischemia is induced.

Microbubble Echocardiography: Contrast Agents and Agitated Saline

Ultrasound Contrast Agents

  • Indications and Clinical Utility:

    • Clear delineation of the left ventricular (LV) endocardial border in technically difficult studies.

    • Improvement of regional wall motion assessment and global Left Ventricular Ejection Fraction (LVEF) calculation.

    • Interrogation and identification of apical/mural LV thrombi (e.g., pedunculated thrombus).

    • Diagnostic evaluation of Hypertrophic Cardiomyopathy (HCM), structural abnormalities like LV non-compaction, and cardiac mass delineation.

    • Enhancement of subtherapeutic spectral Doppler velocity signals (e.g., aortic valve Doppler).

  • American Society of Echocardiography (ASE) Guideline: Contrast agents are indicated when ≥2\ge 2 left ventricular segments are not adequately visualized on non-contrast imaging.

  • Microbubble Characteristics:

    • Microbubble diameter: 1–5 μm1\text{--}5\,\mu\text{m}.

    • Small size allows passage through the pulmonary capillary bed into the left heart chambers.

    • Common Contrast Agents: Definity, Optison, and Lumason.

  • Administration Methods:

    • Intravenous administration via IV bolus (rapid injection) or IV infusion (diluted agent delivered continuously at a slower rate).

    • Requires authorized healthcare staff (nurse, physician, or IV-trained sonographer).

Myocardial Perfusion Imaging (MPI)

  • Mechanism: Advanced technology evaluating contrast microbubble uptake into the myocardial microvasculature.

  • Diagnostic Findings:

    • Microbubbles travel through coronary arteries directly into the endocardium.

    • Adequately perfused LV myocardium shows enhanced echogenicity.

    • Infarcted or non-perfused myocardial segments remain hypoechoic.

Agitated Saline Studies ("Bubble Study")

  • Mechanism and Characteristics:

    • Agitated saline bubbles are larger than vascular contrast microbubbles and cannot pass through intact pulmonary capillaries.

    • In normal anatomy without intracardiac or intrapulmonary shunts, saline bubbles remain strictly within the right heart chambers.

  • Indications:

    • Assessment for persistent interatrial or interventricular shunts.

    • Evaluation of right ventricular (RV) morphology and right-sided valvular flow.

    • Investigation of cardioembolic sources in patients presenting with unexplained Stroke or Transient Ischemic Attack (TIA).

  • Shunt Interpretation Criteria:

    • Right-to-Left Shunt (RT →\rightarrow LT): Rapid appearance of saline microbubbles in the left atrium/left ventricle within 3–63\text{--}6 cardiac cycles post-injection.

    • Provocative Maneuvers: The Valsalva maneuver increases right atrial pressure above left atrial pressure, promoting right-to-left transient flow across patent defects (e.g., Patent Foramen Ovale / PFO).

    • Left-to-Right Shunt (LT →\rightarrow RT): May present as a "negative contrast" jet (a clear area devoid of microbubbles entering the bubble-filled right atrium) or minor transient passage of bubbles into the left heart due to bidirectional to-and-fro flow dynamics.

Alternative Imaging Modalities for Coronary Artery Disease

Cardiac Magnetic Resonance Imaging (cMRI)

  • Mechanism: Uses a high-strength magnetic field to align nuclear spin states of hydrogen atoms within tissues, applying radio-frequency pulses to capture spatial tissue properties.

  • Diagnostic Capabilities:

    • Direct imaging of coronary arteries and atherosclerotic plaque composition.

    • Detailed evaluation of myocardial wall structure, tissue characterization, cardiomyopathies, and viability.

    • Gold standard modality for precise cardiac chamber volumetric measurement and Left Ventricular Ejection Fraction (LVEF).

    • Compatible with pharmacological stress agents.

    • Uses non-iodinated contrast agents (Gadolinium).

Magnetic Resonance Angiography (MRA)

  • Capabilities:

    • Combines MRI pulse sequences with IV contrast enhancement to evaluate vascular anatomy, viability, structural integrity, and chamber dynamics.

    • Acquires 3D volumetric datasets capable of generating planar projections across multi-planar reconstructions.

    • Incorporates emerging Artificial Intelligence (AI) algorithms to detect regional wall motion abnormalities.

Cardiac Computed Tomography (cCT)

  • Mechanism: Multi-detector X-ray imaging producing high-resolution cross-sectional tomographic slices of cardiac structures.

  • Agatston Calcium Score:

    • Quantifies coronary artery calcification; direct correlate to coronary atheromatous plaque burden.

    • An Agatston score >100> 100 serves as an established predictor of major adverse cardiovascular events.

Computed Tomography Angiography (CTA)

  • Capabilities:

    • Utilizes iodinated IV contrast to produce high-resolution 3D reconstructions of coronary artery lumens.

    • Extensively utilized for evaluating peripheral vascular structures, carotid arteries, pulmonary arteries (PA), and the descending aorta with its branches.

    • Patients with documented iodine allergies require specialized alternative non-iodine contrast protocols.